On November 14 , Francesco Landi from the Universita’ Sacro Cuore Roma (Italy) will present ‘The SPRINTT project: changing the paradigm of geriatric research’ in Vienna (Austria).
This presentation will take place during the meeting “Developing interventions for frailty: what do we measure?” organised by the COST Action BM1402:MouseAGE on November from 14 to 15 in Vienna, Austria. More information on this meeting is available on http://www.mouseage.eu/events/developing-interventions-frailty-what-do-we-measure .
What are the Objectives of the SPRINTT project?
To validate an interventional paradigm for identifying at-risk individuals living in the community and evaluate innovative therapeutic interventions against physical frailty and mobility disability, through:
- Creating an operational definition of at-risk (sub-)populations with undisputable unmet therapeutic need
- Qualification of muscular anabolism and catabolism biomarkers in at-risk (sub-) populations
- Validation and implementation of practical clinical methodologies for testing clinically meaningful interventions for the screening, prevention of Physical Frailty and Sarcopenia and its complications (falls, mobility disability, hospitalization, institutionalization)
- Developing scientific and regulatory Consensus on these 3 strategic objectives: therapeutic indication, biomarkers and development clinical methodology
- Developing a health-economic model of physical Frailty and Sarcopenia in a real life setting